Financial hardship for cancer survivors due to high-cost immunotherapies, especially for blood cancer patients

A study published in the Journal of Cancer Survivorship found that cancer survivors receiving high-cost immunotherapy treatments were more likely to face financial hardship, leading to increased instances of being unable to afford care and taking fewer medications due to cost.

Leave A Comment

Your email address will not be published. Required fields are marked *